Literature DB >> 24891774

Effect of leptin and apelin preconditioning on hepatic ischemia reperfusion injury in rats.

Tamer Sagiroglu1, Mustafa Burak Aksoy2, Gonul Sagiroglu3, Hilmi Tozkir4, Serhat Oguz1, Tulin Yalta5, Mehmet A Yagci6, Atakan Sezer1.   

Abstract

Leptin and apelin are important adipocytokines involved in a variety of endocrine and paracrine functions. The aim of this study was to evaluate the effect of exogenous leptin and apelin preconditioning on hepatic ischemia reperfusion (I/R) injury in rats. Forty mice were assigned to four groups (n = 10): sham-operated control (sham), I/R injury, I/R + leptin (I/R + L), and I/R + apelin (I/R + A). Leptin 100 μg/kg/day and apelin 2 μg/kg/day were delivered intraperitoneally starting 3 days prior to surgical procedure in I/R + L and I/R + A groups, respectively. All I/R groups underwent 45 min of warm ischemia, followed by 30 min of reperfusion. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), liver malondialdehyde (MDA) and glutathione (GSH), and liver histopathology were compared between groups. MDA was elevated in I/R, but stayed similar in I/R + L and I/R + A compared to sham. I/R + A had significantly lower MDA compared to I/R. GSH levels did not differ significantly between the groups. ALT and AST were elevated in all I/R groups, but significant reduction was observed in I/R + L and I/R + A compared to I/R. Liver histopathology was mostly mild in I/R + L and I/R + A, in contrast to severe injury observed in the I/R group. Leptin and apelin preconditioning significantly reduced hepatic I/R injury in rats.

Entities:  

Keywords:  Apelin; Ischemia reperfusion injury; Leptin; Liver

Year:  2012        PMID: 24891774      PMCID: PMC4039687          DOI: 10.1007/s12262-012-0676-4

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  35 in total

Review 1.  Molecular mechanisms of liver preconditioning.

Authors:  Elisa Alchera; Caterina Dal Ponte; Chiara Imarisio; Emanuele Albano; Rita Carini
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 2.  Adipocytokines - novel link between inflammation and vascular function?

Authors:  T J Guzik; D Mangalat; R Korbut
Journal:  J Physiol Pharmacol       Date:  2006-12       Impact factor: 3.011

3.  Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.

Authors:  James C Simpkin; Derek M Yellon; Sean M Davidson; Shiang Y Lim; Abigail M Wynne; Christopher C T Smith
Journal:  Basic Res Cardiol       Date:  2007-08-13       Impact factor: 17.165

4.  Apelin-13 protects the heart against ischemia-reperfusion injury through inhibition of ER-dependent apoptotic pathways in a time-dependent fashion.

Authors:  Jianping Tao; Wei Zhu; Yapeng Li; Ping Xin; Jing Li; Mingya Liu; Jingbo Li; Andrew N Redington; Meng Wei
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-29       Impact factor: 4.733

5.  Leptin relieves intestinal ischemia/reperfusion injury by promoting ERK1/2 phosphorylation and the NO signaling pathway.

Authors:  Zi-Hui Deng; Guang-Tao Yan; Lu-Huan Wang; Jin-Ying Zhang; Hui Xue; Kai Zhang
Journal:  J Trauma Acute Care Surg       Date:  2012-01       Impact factor: 3.313

6.  Apelin, a newly identified adipokine up-regulated by insulin and obesity.

Authors:  Jérémie Boucher; Bernard Masri; Danièle Daviaud; Stéphane Gesta; Charlotte Guigné; Anne Mazzucotelli; Isabelle Castan-Laurell; Ivan Tack; Bernard Knibiehler; Christian Carpéné; Yves Audigier; Jean-Sébastien Saulnier-Blache; Philippe Valet
Journal:  Endocrinology       Date:  2005-01-27       Impact factor: 4.736

7.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.

Authors:  K Tatemoto; M Hosoya; Y Habata; R Fujii; T Kakegawa; M X Zou; Y Kawamata; S Fukusumi; S Hinuma; C Kitada; T Kurokawa; H Onda; M Fujino
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

8.  Pharmacological preconditioning with simvastatin protects liver from ischemia-reperfusion injury by heme oxygenase-1 induction.

Authors:  I-Rue Lai; King-Jen Chang; Hsiu-Wen Tsai; Chau-Fong Chen
Journal:  Transplantation       Date:  2008-03-15       Impact factor: 4.939

9.  Effect of pharmacologic preconditioning with tetrandrine on subsequent ischemia/reperfusion injury in rat liver.

Authors:  Zhongmin Liu; Zhenping Xu; Wenlu Shen; Yi Li; Jun Zhang; Xin Ye
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

10.  Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.

Authors:  István Szokodi; Pasi Tavi; Gábor Földes; Sari Voutilainen-Myllylä; Mika Ilves; Heikki Tokola; Sampsa Pikkarainen; Jarkko Piuhola; Jaana Rysä; Miklós Tóth; Heikki Ruskoaho
Journal:  Circ Res       Date:  2002-09-06       Impact factor: 17.367

View more
  3 in total

1.  Protective effect of apelin preconditioning in a rat model of hepatic ischemia reperfusion injury; possible interaction between the apelin/APJ system, Ang II/AT1R system and eNOS.

Authors:  Maha M Sabry; Nagwa M Ramadan; Basant A Al Dreny; Laila A Rashed; Ayman Abo El Enein
Journal:  United European Gastroenterol J       Date:  2019-01-23       Impact factor: 4.623

Review 2.  The Role of the Apelin/APJ System in the Regulation of Liver Disease.

Authors:  Xinrui Lv; Jing Kong; Wei-Dong Chen; Yan-Dong Wang
Journal:  Front Pharmacol       Date:  2017-04-24       Impact factor: 5.810

Review 3.  Apelin/APJ system: A key therapeutic target for liver disease.

Authors:  Shuang-Yu Lv; Binbin Cui; Wei-Dong Chen; Yan-Dong Wang
Journal:  Oncotarget       Date:  2017-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.